Related Content
- Walgreens puts its money where its mouth is with World AIDS Day campaign
- With health reform outlook dimmed, pharmacy can’t abandon its agenda
- Medication adherence could be blockbuster for specialty
- Walgreens launches high-impact push in support of World AIDS Day campaign
- Walgreens allies with HHS to launch free flu shot outreach to disadvantaged
SCHAUMBURG, Ill. Generic drug maker Sagent Pharmaceuticals has launched two injectable antibiotics, the company said Tuesday.
Sagent announced the launch of ampicillin and ampicillin with sulbactam. Ampicillin had sales of around $42 million during the 12-month period ended in June, while ampicillin with sulbactam had sales of around $40 million during the same period, according to IMS Health.
“The launch of these products increases Sagent’s anti-infectives portfolio to 11 injectable products in a variety of sizes, concentrations and packaging configurations,” Sagent CEO and board chairman Jeffrey Yordon said.
